What does CUSIP 15117B903 represent in this 13F holders report?

CUSIP 15117B903 is the security identifier for 15117B903 - CELLDEX THERAPEUTICS INC NEW - COM - Call used to aggregate holder disclosures.

How many institutions held 15117B903 - CELLDEX THERAPEUTICS INC NEW - COM - Call in Q2 2017?

No institutional holders were reported for 15117B903 - CELLDEX THERAPEUTICS INC NEW - COM - Call in Q2 2017; review adjacent reporting periods for trend context.

CELLDEX THERAPEUTICS INC NEW - COM - Call

CUSIP: 15117B903

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / COM
Price per share: $3.09
Number of holders: 0

Quarterly Holders Quick Answers

What is CUSIP 15117B903?
CUSIP 15117B903 identifies 15117B903 - CELLDEX THERAPEUTICS INC NEW - COM - Call in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 15117B903:

Q4 2018 Q3 2018 Q2 2018 Q1 2018 Q4 2017 Q3 2017 Q2 2017 Q1 2017

CELLDEX THERAPEUTICS INC NEW - COM - Call

Q2 2017 13F Holders as of 30 Jun 2017

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of CELLDEX THERAPEUTICS INC NEW - COM - Call as of Q2 2017.